Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Interactive multimedia to teach the life cycle of Trypanosoma cruzi, the causative agent of Chagas disease.

Teixeira DE, Benchimol M, Crepaldi PH, de Souza W.

PLoS Negl Trop Dis. 2012 Aug;6(8):e1749. doi: 10.1371/journal.pntd.0001749. No abstract available.

2.

Does inhibition of Trypanosoma cruzi key enzymes affect parasite life cycle and geographic distribution?

Salvati L, Bolognesi M, Ascenzi P.

IUBMB Life. 2002 Jan;53(1):45-7. Review.

3.

Dinitroaniline herbicides against protozoan parasites: the case of Trypanosoma cruzi.

Traub-Cseko YM, Ramalho-Ortigão JM, Dantas AP, de Castro SL, Barbosa HS, Downing KH.

Trends Parasitol. 2001 Mar;17(3):136-41. Review.

PMID:
11286798
4.

Trypanosoma cruzi infection beats the B-cell compartment favouring parasite establishment: can we strike first?

Acosta Rodriguez EV, Zuniga EI, Montes CL, Merino MC, Bermejo DA, Amezcua Vesely MC, Motran CC, Gruppi A.

Scand J Immunol. 2007 Aug-Sep;66(2-3):137-42. Review.

5.

The uniqueness of the Trypanosoma cruzi mitochondrion: opportunities to identify new drug target for the treatment of Chagas disease.

Lisvane Silva P, Mantilla BS, Barisón MJ, Wrenger C, Silber AM.

Curr Pharm Des. 2011;17(20):2074-99. Review.

PMID:
21718252
6.

Chemokines, inflammation and Trypanosoma cruzi infection.

Teixeira MM, Gazzinelli RT, Silva JS.

Trends Parasitol. 2002 Jun;18(6):262-5. Review.

PMID:
12036740
7.

[Pathogenesis of Chagas' disease].

Tafuri WL.

Rev Inst Med Trop Sao Paulo. 1987 Jul-Aug;29(4):194-9. Review. Portuguese. No abstract available.

PMID:
3130653
8.

The challenge of Chagas' disease: has the human pathogen, Trypanosoma cruzi, learned how to modulate signaling events to subvert host cells?

Lima FM, Oliveira P, Mortara RA, Silveira JF, Bahia D.

N Biotechnol. 2010 Dec 31;27(6):837-43. doi: 10.1016/j.nbt.2010.02.003. Review.

PMID:
20172059
9.

Trypanosoma cruzi, the etiologic agent of Chagas' disease: status in the blood supply in endemic and nonendemic countries.

Schmuñis GA.

Transfusion. 1991 Jul-Aug;31(6):547-57. Review. No abstract available.

PMID:
1906650
10.

Interactions between intestinal compounds of triatomines and Trypanosoma cruzi.

Garcia ES, Genta FA, de Azambuja P, Schaub GA.

Trends Parasitol. 2010 Oct;26(10):499-505. doi: 10.1016/j.pt.2010.07.003. Review.

PMID:
20801082
11.

Experimental Chagas disease: phagocytosis of apoptotic lymphocytes deactivates macrophages and fuels parasite growth.

Lopes MF, DosReis GA.

Apoptosis. 2000 Jun;5(3):221-4. Review. No abstract available.

PMID:
11225843
12.

Implications of genetic variability of Trypanosoma cruzi for the pathogenesis of Chagas disease.

Manoel-Caetano Fda S, Silva AE.

Cad Saude Publica. 2007 Oct;23(10):2263-74. Review.

13.

Glucose metabolism in Trypanosoma cruzi.

Maugeri DA, Cannata JJ, Cazzulo JJ.

Essays Biochem. 2011;51:15-30. doi: 10.1042/bse0510015. Review.

PMID:
22023439
14.

Don't bother to knock--the cell invasion strategy of Trypanosoma cruzi.

Tan H, Andrews NW.

Trends Parasitol. 2002 Oct;18(10):427-8. Review.

PMID:
12377585
Items per page

Supplemental Content

Support Center